Individual and Synergistic Potential of Bioactive Compounds from Chrysopogon Zizanioides Against Main-Protease of SARSCov-2 using Computational Approach

Author:

Ragunathan Venkataraghavan1ORCID,Ramakrishnan Thiruchelvi2ORCID,Narayanan Rajnish3ORCID

Affiliation:

1. 1Department of Chemical Engineering, Alagappa College of Technology, Anna University, Chennai 600025, Tamil Nadu, India

2. 2Department of Bio-Engineering, School of Engineering, Vels Institute of Science Technology and Advanced Studies, Pallavaram, Chennai 600117, Tamil Nadu, India

3. 3Department of Genetic Engineering, SRM Institute of Science and Technology, Kattankulathur, 603203, Tamil Nadu, India

Abstract

This study presents the anti-COVID potential of bioactive compounds from Chrysopogon zizanioides thorough in-silico molecular docking approach using AutoDock Vina software. As of our knowledge, the antiviral potential of all its bioactive compounds and their synergistic potentials against SARS-CoV-2 main-protease is not reported earlier. The results were promising with ß-Sitosterol (?G = -7.5 kcal/mol; Ki = 3.13 µM); Campesterol (?G = -7.4 kcal/mol; Ki = 3.71 µM); Stigmast-4-en-3-one (?G = -7.3 kcal/mol; Ki = 4.39 µM) forming noncovalent interactions with the amino acids in the active site of Mpro causing inhibition. The synergistic potential of compounds showed a significant sign of inhibition against Mpro with -7.9 kcal/mol with the sequential combination of ß-Sitosterol; Campesterol; Stigmast-4-en-3-one. The docking protocol validation was performed by re-docking and superimposing co-crystallized ligand, and interactions visualized using Discovery Studio 2020. Moreover, all the compounds satisfied Lipinski’s oral drug-likeliness properties to be used and oral drug. These bioactive compounds of Chrysopogon zizanioides showed low binding energies against SARS-CoV-2 Mpro which proved their anti-COVID potential. Thus, by incorporating Chrysopogon zizanioides for consumption in daily life, it is very likely that one can get rid of COVID-19.

Publisher

Oriental Scientific Publishing Company

Subject

Drug Discovery,Agronomy and Crop Science,Biotechnology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3